These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20360125)

  • 1. Establishing a clinical basis for hsCRP in the prevention and treatment of cardiovascular disease.
    Ridker PM
    Clin Chem; 2010 Jul; 56(7):1186-7. PubMed ID: 20360125
    [No Abstract]   [Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Ridker PM
    Circulation; 2001 Apr; 103(13):1813-8. PubMed ID: 11282915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An ultrasensitive C-reactive protein assay--a new parameter in cardiovascular risk].
    Dvoráková A; Poledne R
    Vnitr Lek; 2004 Nov; 50(11):852-7. PubMed ID: 15648966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.
    Aulin J; Siegbahn A; Hijazi Z; Ezekowitz MD; Andersson U; Connolly SJ; Huber K; Reilly PA; Wallentin L; Oldgren J
    Am Heart J; 2015 Dec; 170(6):1151-60. PubMed ID: 26678637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of C-reactive protein for cardiovascular disease detection and prevention.
    Ridker PM
    Circulation; 2003 Jan; 107(3):363-9. PubMed ID: 12551853
    [No Abstract]   [Full Text] [Related]  

  • 6. The Use of High Sensitivity C-Reactive Protein in Cardiovascular Disease Detection.
    Castro AR; Silva SO; Soares SC
    J Pharm Pharm Sci; 2018; 21(1):496-503. PubMed ID: 30496036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of biomarkers for risk stratification in the prevention of cardiovascular diseases].
    Sinning C; Keller T; Blankenberg S
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2019-22. PubMed ID: 19777420
    [No Abstract]   [Full Text] [Related]  

  • 8. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
    Muhlestein JB; May HT; Galenko O; Knowlton KU; Otvos JD; Connelly MA; Lappe DL; Anderson JL
    Am Heart J; 2018 Aug; 202():27-32. PubMed ID: 29803983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond cholesterol: a new clue to heart disease.
    Johns Hopkins Med Lett Health After 50; 2003 Mar; 15(1):4-5. PubMed ID: 12703447
    [No Abstract]   [Full Text] [Related]  

  • 10. Dermatologic surgery emergencies: Complications caused by occlusion and blood pressure.
    Minkis K; Whittington A; Alam M
    J Am Acad Dermatol; 2016 Aug; 75(2):243-62. PubMed ID: 27444068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of C-reactive protein in ischemic cardiopathy].
    Bazzino O; Natale E
    Medicina (B Aires); 2001; 61(2):239-42. PubMed ID: 11374151
    [No Abstract]   [Full Text] [Related]  

  • 12. The renaissance of C reactive protein.
    Pepys MB; Berger A
    BMJ; 2001 Jan; 322(7277):4-5. PubMed ID: 11141130
    [No Abstract]   [Full Text] [Related]  

  • 13. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?
    Sellmayer A; Limmert T; Hoffmann U
    Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and coronary heart disease.
    Foody JM; Gotto AM; Wenger N
    N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257565
    [No Abstract]   [Full Text] [Related]  

  • 15. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical application of C-reactive protein in prognosis and prevention of cardiovascular disease].
    Feng RF
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1370-3. PubMed ID: 14584491
    [No Abstract]   [Full Text] [Related]  

  • 17. Reproducibility in serial C-reactive protein and interleukin-6 measurements in post-myocardial infarction patients: results from the AIRGENE study.
    Karakas M; Baumert J; Greven S; Rückerl R; Peters A; Koenig W
    Clin Chem; 2010 May; 56(5):861-4. PubMed ID: 20299677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fire that burns within: C-reactive protein.
    Kereiakes DJ
    Circulation; 2003 Jan; 107(3):373-4. PubMed ID: 12551855
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.
    Ridker PM; Cook N
    Circulation; 2004 Apr; 109(16):1955-9. PubMed ID: 15051634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of high sensitivity C-reactive protein in cardiology.
    Adukauskienė D; Čiginskienė A; Adukauskaitė A; Pentiokinienė D; Šlapikas R; Čeponienė I
    Medicina (Kaunas); 2016; 52(1):1-10. PubMed ID: 26987494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.